• Facebook
  • Rss
  • Twitter
  • Youtube
  • Store
  • Donate
NCCS - National Coalition for Cancer Survivorship
  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Survivorship Champions
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Honorees
      • Sponsors
      • Committees
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Cancer Policy Roundtable
      • Spring 2021 Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us
  • Search
  • Menu Menu
  • 0Shopping Cart

Year-End MATCH (DEADLINE Dec 31): Donate & Make a Difference | Donate

20years

Guest Post by Dr. Claire Snyder: Driving Quality Cancer Care with Patient-Reported Outcomes

March 24, 2015/in Cancer News, Cancer Policy Blog Quality Cancer Care, Quality Measurement, Survivorship Care NCCS News /by actualize
snyder_headshot_2014

Guest post by Claire Snyder, PhD

Twenty years ago, the National Coalition for Cancer Survivorship’s Imperatives for Quality Cancer Care advocated that “standards of cancer care should be driven by the quality of care.” By giving voice to the patient perspective, patient-reported outcomes (PROs) play a key role in assessing and improving the quality of care and, therefore, in setting these critical standards. PROs are measurements that come directly from the patient’s perception about health, disease or treatment, without amendment or interpretation by a clinician or anyone else. PRO is an umbrella term that can refer to symptoms, functioning, treatment satisfaction, and health-related quality of life, among other measures. PROs are playing an increasingly prominent role in both assessing and improving cancer care quality.

Traditionally, PROs were outcomes measured in clinical trials and other research studies and provided patients the opportunity to report on the impact of treatments on their functioning and well-being. The PRO results could then be used by patients and clinicians to evaluate the relative advantages and disadvantages of treatment options. Building on this traditional use, there has been increasing interest in routinely assessing PROs and using those data to inform individual patient’s care. For example, in our institution, we developed the PatientViewpoint webtool (www.PatientViewpoint.org), which allows clinicians to order PRO questionnaires for patients to complete – much as they would order a laboratory test or imaging study. The PRO results are available to the patient and clinician to improve communication about patients’ functioning and well-being, as demonstrated here:

There is also the potential to aggregate the PRO results across patients in a clinic, health plan, or other organization to evaluate care quality. Linking the PRO data with other clinical measures further increases the possibilities of using the PROs for comparative effectiveness and patient-centered outcomes research to set standards for quality.

To support the use of PROs to give voice to the patient in cancer care quality, the International Society for Quality of Life Research has undertaken a number of initiatives, including developing a User’s Guide for Implementing PROs in Clinical Practice and tools to improve the reporting and interpretation of PRO clinical trial results. In some of our own research supported by the Patient-Centered Outcomes Research Institute, and with representation from NCCS, we are investigating best practices for presenting research study and individual patient PRO data to patients and clinicians to improve understanding and use of PRO results to promote quality care. By integrating PROs in patient care and research, we ensure that the patient’s voice drives the standards for quality cancer care.

Claire Snyder, PhD, is Associate Professor of Medicine, Oncology, and Health Policy & Management at The Johns Hopkins Schools of Medicine and Public Health in Baltimore, Maryland and Director of the Program for Building Lifestyle, Outcomes, and Care Services Research in Cancer at Johns Hopkins.  She is also President-Elect of the International Society for Quality of Life Research. The views & opinions expressed in any guest post featured on our site are those of the guest author and do not necessarily reflect the opinions & views of the National Coalition for Cancer Survivorship. Read our blog and comment policies here.

Tags: 20 Years Later, cancer care, Cancer Survivorship, Guest Post, patient first, patient-reported outcomes, PCORI, quality
Share this entry
  • Share on Facebook
  • Share on Twitter
https://canceradvocacy.org/wp-content/uploads/2015/01/20years.gif 500 500 actualize https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png actualize2015-03-24 12:40:562020-10-21 12:08:44Guest Post by Dr. Claire Snyder: Driving Quality Cancer Care with Patient-Reported Outcomes
You might also like
importance of advancing survivorship Guest Post: Important To Weigh In On Survivorship Issues For Moonshot
NCCS Starburst 250px Health Care Roundup: Medicare ‘Step Therapy’ Concerns; Alternative Cancer Treatment Risks; Immunotherapy Scientists Win Nobel Prize; More
Fotolia 23428619 S e1461260836640 Reps. DeSaulnier and Poe Introduce Bipartisan “Cancer Care Planning and Communications Act”
Betsy Glosik blog fb Seeing the Bigger Picture of Survival Through Patient Advocacy
NCCS Presents 5th Annual Ellen L. Stovall Award to Julia H. Rowland, PhD and Thomas J. Smith, MD for Their Innovation and Dedication to Cancer Survivors
Elevating Survivorship Logo web FB TW NCCS Elevate Ambassador Kimberly Richardson Launches Educational Program to Pair Scientists with Cancer Survivors
dome Medicare Care Choices Program and Cancer Care Planning for Medicare Beneficiaries
Balancing Patient Protections and Innovation Balancing Patient Protections and Innovation: NCCS Applauds FDA Action to Regulate Laboratory-Developed Tests

Latest News

NCCS Founders at 1990 Assembly

The Birth of the Cancer Survivorship Movement and How It Transformed Cancer Care for Millions

March 25, 2021
Guest Post by Judith L. Pearson Best-Selling Author of From Shadows to Life: A Biography…
Read more
https://canceradvocacy.org/wp-content/uploads/2018/02/10-Founders-1990-NCCS-Assembly.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-25 10:36:202021-03-25 13:46:05The Birth of the Cancer Survivorship Movement and How It Transformed Cancer Care for Millions
HHS Humphrey bldg 1200

Biden Rescinds Trump Admin Proposal to Limit Medicare Part D Coverage of Drugs in “Six Protected Classes”

March 19, 2021
This week, the Biden administration rescinded a Trump administration-proposed plan…
Read more
https://canceradvocacy.org/wp-content/uploads/2017/10/HHS-Humphrey-bldg-1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-19 13:36:192021-03-23 14:46:18Biden Rescinds Trump Admin Proposal to Limit Medicare Part D Coverage of Drugs in “Six Protected Classes”
CDC Headquarters

NCCS Recommends That States Allocate COVID-19 Vaccines to Cancer Care Providers

March 1, 2021
The National Coalition for Cancer Survivorship (NCCS) and the Cancer Leadership Council…
Read more
https://canceradvocacy.org/wp-content/uploads/CDC_Headquarters_PHIL_pubdomain_1200.jpg 600 1200 NCCS Staff https://canceradvocacy.org/wp-content/uploads/2020/06/NCCA-Logo.png NCCS Staff2021-03-01 15:49:432021-03-04 17:45:07NCCS Recommends That States Allocate COVID-19 Vaccines to Cancer Care Providers

Take Action

Stovall Award

The Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care is a unique opportunity for patients and survivors to recognize pioneers who are transforming the cancer care system.

Join CPAT

The NCCS Cancer Policy & Advocacy Team (CPAT) is a program for survivors and caregivers to learn about pressing policy issues that affect quality cancer care in order to be engaged as advocates in public policy around the needs of cancer survivors.

Share Your Story

NCCS represents the millions of Americans who share a common experience – the survivorship experience – living with, through and beyond a cancer diagnosis.

STAY CONNECTED

Together we can improve cancer care for survivors! Sign up to be the first to know about cancer policy issues and ways to take action

  • About
    • Our Mission
    • Our History
    • Our Leadership
      • Policy Advisors
    • Employment
    • Partnerships
    • Financial Information
  • Policy
    • Quality Cancer Care
    • Access to Care
    • Health Equity
    • Redefining Functional Status (RFS)
    • 2020 State of Cancer Survivorship Survey
    • Cancer Care Planning and Communications Act (CCPCA)
  • Get Involved
    • What is Advocacy?
    • Cancer Policy and Advocacy Team (CPAT)
    • Elevating Survivorship
    • Survivor Stories
    • Cancerversary
    • State Based Cancer Advocacy
  • Resources
    • COVID-19 Resources for Cancer Survivors
    • Survivorship Checklist
    • Cancer Survival Toolbox
    • Telehealth
    • Survivorship Champions
    • Publications
      • Talking With Your Doctor
      • Self Advocacy
      • Employment Rights
      • Remaining Hopeful
    • Cancer Convos Podcast
    • Taking Charge of Your Care
    • Care Planning for Cancer Survivors
    • Tools For Care Providers
    • Order Our Resources
  • News
  • Events
    • Ellen L. Stovall Award
      • Nominations
      • Honorees
      • Sponsors
      • Committees
    • From Shadows to Life: A Biography of the Cancer Survivorship Movement
    • Cancer Policy Roundtable
      • Spring 2021 Cancer Policy Roundtable
      • Fall 2020 Cancer Policy Roundtable
      • Spring 2020 Cancer Policy Roundtable
    • Cancer Policy and Advocacy Team (CPAT) Symposium 2020
    • Webinars
  • Contact Us

National Coalition for Cancer Survivorship
8455 Colesville Road  |  Suite 930  |  Silver Spring, MD 20910
877-NCCS-YES  |  info@canceradvocacy.org
Privacy Policy  |  Terms and Conditions

Copyright © 1995-2021 by the National Coalition for Cancer Survivorship
National Coalition for Cancer Survivorship, NCCS, Cancer Survival Toolbox, and related Logos are registered in the United States as trademarks of the National Coalition for Cancer Survivorship.

Guest Post by Dr. Michael Neuss Introduces the Third Imperatives Principle:... 20years NCCS Starburst Thumbnail National Coalition for Cancer Survivorship Joins the Health Care Payment Learning...
Scroll to top

Harmar Brereton, MD

Founder
Northeast Regional Cancer Institute

 

“Perhaps one of the most impactful collaborations in Dr. Brereton’s extraordinary career remains his early work and long friendship with Ellen Stovall. Through him, and in turn through the thousands of lives he has touched, Ellen’s work continues, and her mission lives on.”

—Karen M. Saunders
President, Northeast Regional Cancer Institute